期刊文献+

胃癌患者术前免疫状态及影响因素 被引量:3

IMMUNE STATE AND INFLUENTIAL FACTORS IN PATIENTS WITH GASTRIC CANCER BEFORE OPERATION
下载PDF
导出
摘要 通过检测50例胃癌患者和30例非肿瘤患者外周血NK细胞活性和T细胞亚群来研究胃癌患者术前免疫状态及其影响因素。结果显示:术前胃癌患者免疫功能明显低于非肿瘤患者,而且胃癌患者免疫功能随着病期的进展呈进行性下降,但其免疫状态与肿瘤类型无明显直接关系,与患者的年龄、性别也无关系。而肿瘤患者术前免疫状态与肿瘤病灶大小有直接关系,即病期越晚,肿瘤病灶越大,免疫功能越低。这进一步提示肿瘤患者的免疫抑制是肿瘤源性的,可能由肿瘤细胞分泌的免疫抑制因子所造成。因此应尽可能地切除肿瘤组织以改善患者的免疫状态。 For analysing the immune state and influential factors in patients with gastric cancer before operation,NK cell activity and T - lymphocyte subsets in periphral blood were tested in 50 cases gastric cancer patients and 30 cases non - tu-morous patients. The results showed that before operation the immune function of the patients with gastric cancer was lower than non-tumor patients,and also decreased progressively with the deterioration of the disease before operation. However, there was neither direct correlation between the degree of malignancy and the pre- operation immune state and nor direct cor-relation between the pre -operative immune state and sex or age of the patients. The results suggested that the pre- operation immune state was directly correlated with the size of the tumor,the more advanced stage and larger tumor,the lower immune function. This further indicates that the immunosuppression originated from the tumor,the hypoimmunity was basically at-tributed to the immune inhibition fator from tumorous cells,which means the necessity of the removal of tumorous tissue to improve the immune state of the patients.
出处 《临床肿瘤学杂志》 CAS 1996年第2期4-7,共4页 Chinese Clinical Oncology
关键词 胃癌 手术 免疫学 免疫抑制 肿瘤 Stomach neoplasms , Adenocarcinoma , Immunosuppression
  • 相关文献

参考文献2

  • 1李中华,许荣,洪鹤群,王长安,朱寿柱,林言箴.胃癌病人外周血自然杀伤细胞活性的研究[J]中国免疫学杂志,1987(02).
  • 2Tetsuya Toge MD,Akira Kameda,Hirofumi Yamada,Yoshihiro Seto,Kiyoshi Aratani,Tsuyoshi Fujita,Takao Hattori. Role of the spleen on immunosuppression in esophageal and gastric cancer[J] 1986,The Japanese Journal of Surgery(5):330~335

同被引文献15

  • 1慢性乙型肝炎防治指南[J].肝脏,2005,10(4):348-357. 被引量:272
  • 2孙景勇,倪语星.血液病房细菌耐药监测[J].中华医院感染学杂志,2006,16(2):206-208. 被引量:11
  • 3李中华.胃癌患者外周血自然杀伤细胞活性的研究[J].中国免疫学杂志,1987,3(1):81-83.
  • 4Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology, 2007, 45 : 507- 539.
  • 5Lo N, Cullen M. Antibiotic prophylaxis in chemotherapy-induced neutropenia: time to reconsider. Hematol Oncol, 2006, 24 ( 3 ) : 120-125.
  • 6Holmes FA, Jones SE, O' Shaughnessy J, et al. Comparable efficacy and safety profiles of once-per-cycle pegfilgrastira and daily injection filgrastira in chemotherapy-induced neutrepenia: a muhieenter dose- finding study in women with breast cancer. Ann Oncol, 2002, 13: 903 -909.
  • 7Timmer-Bonte JN, de Boo TM, Smit H J, et al. Prevention of chemo- therapy-induced febrile neutropcnia by prophylactic antibiotics plus or minus granulocytc colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study. J Clin Oncol, 2005, 23:7974-7984.
  • 8Eleutherakis-Papaiakovou E, Kostis E, Migkou M, et al. Prophylactic antibiotics for the prevention of neutropertie fever in patients undergoing autologous stem-eel1 transplantation results of a single institution, randomized phase 2 trial. Am J Hematol, 2010, 85:863-867.
  • 9Cullen M, Baijal S. Prevention of febrile neutropenia: use of prophylactic antibiotics. Br J Cancer, 2009, 101 ( Suppl 1 ) : S11 -S14.
  • 10Lotze M T,Finn O J. Recent Advance in Cellular Immunology: Implications for Immunity to Cancer[J]. Immunol Today, 1990,11(6) ;190.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部